We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Cocoa Flavanols (flavanol-rich cocoa extract)
Flavanol-rich extract from cocoa beans, standardized for epicatechin. The largest trial (COSMOS, 21,442 adults) MISSED its primary cardiovascular endpoint but cut CVD death by 27% as a secondary outcome. Meta-analyses show a small (~2 mmHg) blood-pressure drop and improved endothelial function; cognitive benefit in the same trial was null.
What the evidence says
Most Cocoa Flavanols studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2003–2026 with a typical study size of 666 participants.
Based on 84 studies · 5 meta-analyses · 71 RCTs · 43,478 total participants
Confidence
High confidenceBy outcome
Meta-analyses consistently show a small (~2 mmHg) blood-pressure drop and improved endothelial function, but the large COSMOS trial missed its primary cardiovascular endpoint and cognitive benefit was null — supporting a moderate score.
82 rigorous studies
72 randomized trials · 3 meta-analyses · 10 systematic reviews
Our evidence rating for Cocoa Flavanols is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
8 trials ongoing or recruiting · 50 completed on ClinicalTrials.gov
5 of the completed trials have posted results
Registered trials show research momentum for Cocoa Flavanols, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Sep 2026
Under EU law (Reg. 1924/2006), EFSA reviews whether a specific health claim for Cocoa Flavanols meets the evidence standard. These are independent regulatory decisions on claims — not studies, and never counted toward the evidence score above.
Not authorised by EFSA
“Cocoa flavanols Maintenance and promotion of a normal blood pressure”
“Not authorised” means the specific claim wording did not meet the EU’s evidence standard — often a matter of dossier or phrasing, not proof of no effect. EFSA judges marketing claims and is kept separate from our study-based evidence score.
Source: EU Register of nutrition and health claims (European Commission / EFSA) · register snapshot Feb 2013
Cocoa flavanols are polyphenols (chiefly epicatechin and procyanidins) concentrated from cocoa beans into standardized extracts. The headline trial is COSMOS (2022) — a randomized, double-blind, placebo-controlled trial in 21,442 older US adults taking 500mg cocoa flavanols daily for a median 3.6 years.
Reported honestly: the PRIMARY endpoint (total cardiovascular events) was NOT statistically significant (HR 0.90, 95% CI 0.78-1.02, P=0.11).
However, a secondary endpoint — cardiovascular death — was reduced by 27% (HR 0.73, 95% CI 0.54-0.98), and per-protocol analysis (accounting for nonadherence) did show a lower risk of total CV events.
Supporting mechanism trials and meta-analyses are more consistent: a Cochrane review found flavanol-rich cocoa lowers blood pressure by about 2 mmHg short-term, and a dose-response meta-analysis found improved flow-mediated dilation (endothelial function), optimal near 710mg flavanols.
Cognition is a genuine mixed bag: an early Brickman RCT linked flavanols to better dentate-gyrus-dependent memory, but the large COSMOS-Mind sub-trial found NO cognitive benefit from cocoa extract over 3 years.
Net: a plausible vascular benefit with one positive secondary mortality signal, but the primary outcome was negative and cognitive claims are not supported by the best trial.
Epicatechin enhances endothelial nitric-oxide production, promoting vasodilation and improved flow-mediated dilation.
Improved vascular tone produces a small (~2 mmHg) short-term reduction in blood pressure, larger in (pre)hypertensive people.
Flavanols increase hippocampal/cerebral blood volume in imaging studies — the proposed basis for any cognitive effect (which the largest trial did not confirm).
How Cocoa Flavanols works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Take earlier in the day; choose lower-caffeine extracts.
Dietary cocoa is fine; standardized high-dose extracts are not specifically studied — use food sources or consult a clinician.
Additive small blood-pressure-lowering effect — generally benign but worth noting if BP is already well controlled.
Cocoa contains theobromine and modest caffeine; may affect sensitive individuals if taken late in the day.
Tip: Take with food; reported by ~1% in the Cochrane review
Cocoa Flavanols has an evidence score of 5/10 — moderate evidence based on 77 indexed studies, including 2 meta-analyses. Flavanol-rich extract from cocoa beans, standardized for epicatechin. The largest trial (COSMOS, 21,442 adults) MISSED its primary cardiovascular endpoint but cut CVD death by 27% as a secondary outcome. Meta-analyses show a small (~2 mmHg) blood-pressure drop and improved endothelial function; cognitive benefit in the same trial was null. Representative study: PMID 28439881.
The commonly studied dose of Cocoa Flavanols is 500-750mg cocoa flavanols daily (COSMOS used 500mg; endothelial benefit peaked near 710mg). Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Cocoa Flavanols — consistent daily use matters more than the time of day. No strong timing dependence; can be split.
Cocoa Flavanols is generally well-tolerated and considered safe for most healthy adults at recommended doses. Reported side effects are uncommon and include mild GI complaints / nausea. Use caution if any of these apply to you: Caffeine sensitivity (cocoa contains some caffeine/theobromine); Caution with the added sugar/fat if consumed as chocolate.
Ginkgo Biloba
Probably helpsStandardized leaf extract with modest meta-analytic benefit in dementia and mild cognitive impairment — but no measurable cognitive benefit in healthy adults and no effect on preventing dementia.
Bacopa Monnieri
Mostly mechanism / observationalEnhances memory formation and recall by supporting synaptic communication — benefits build over 8-12 weeks of consistent use.
Grape Seed Extract
Likely helpsRich source of oligomeric proanthocyanidins (OPCs) that support circulation, skin health, and antioxidant defense.
Panax Ginseng
Likely helpsGinsenosides combat fatigue, sharpen cognitive function, and enhance stress resilience — distinct from American and Siberian ginseng.
Explore: Best supplements for Vitality & LongevityBest supplements for Focus, Memory & Mood
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 84 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research